Cargando…

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota

Proton pump inhibitors (PPIs) are the most used acid-inhibitory drugs, with a wide range of applications in the treatment of various digestive diseases. However, recently, there has been a growing number of digestive complications linked to PPIs, and several studies have indicated that the intestina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Liang, Huang, Chongfei, Fu, Wenkang, Gao, Long, Mi, Ningning, Bai, Mingzhen, Ma, Haidong, Zhang, Chao, Lu, Yawen, Zhao, Jinyu, Zhang, Xianzhuo, Jiang, Ningzu, Lin, Yanyan, Yue, Ping, Yuan, Jinqiu, Meng, Wenbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387554/ https://www.ncbi.nlm.nih.gov/pubmed/37529701 http://dx.doi.org/10.3389/fphar.2023.1217306

Ejemplares similares

The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease
por: Cai, Teng, et al.
Publicado: (2022)

Saline irrigation for reducing the recurrence of common bile duct stones after lithotripsy: a randomized controlled trial
por: Lin, Yanyan, et al.
Publicado: (2023)

The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review
por: Zhang, Xianzhuo, et al.
Publicado: (2023)

Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma
por: Gao, Long, et al.
Publicado: (2023)

Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma
por: Gao, Long, et al.
Publicado: (2023)

The role of extracellular vesicles in cholangiocarcinoma
por: Bai, Mingzhen, et al.
Publicado: (2020)

Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis
por: Mi, Ningning, et al.
Publicado: (2020)

Phosphoproteomics reveals that cinobufotalin promotes intrahepatic cholangiocarcinoma cell apoptosis by activating the ATM/CHK2/p53 signaling pathway
por: Xia, Zhili, et al.
Publicado: (2022)

Digestive disorders and Intestinal microbiota
por: Antonio, Nouvenne, et al.
Publicado: (2018)

Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota
por: Zhang, Jiayi, et al.
Publicado: (2023)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

COVID-19 Mortality: The Culprit May Not Be Proton Pump Inhibitors
por: Duan, Zhihui, et al.
Publicado: (2022)

Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver
por: Assalin, Heloisa B., et al.
Publicado: (2022)

Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota
por: Tanigawa, Tetsuya, et al.
Publicado: (2021)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
por: Tsuda, Ayumi, et al.
Publicado: (2015)

Can proton pump inhibitors cause intestinal inflammation in children?
por: Kang, Ben
Publicado: (2019)

Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics
por: Revaiah, Pruthvi C, et al.
Publicado: (2018)

Proton pump inhibitor use associated with changes in gut microbiota composition
por: Reveles, Kelly R, et al.
Publicado: (2018)

Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors
por: Hojo, Mariko, et al.
Publicado: (2018)

Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro
por: Lepczyńska, Małgorzata, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients
por: Benus, Robin F., et al.
Publicado: (2010)

Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease
por: Zheng, Ya-Mei, et al.
Publicado: (2021)

A comparison of digestive strategies for fishes with different feeding habits: Digestive enzyme activities, intestinal morphology, and gut microbiota
por: Jiao, Fang, et al.
Publicado: (2023)

Use of proton pump inhibitor may be associated with progression of cerebral small vessel disease
por: Kang, Min Kyoung, et al.
Publicado: (2022)

Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials
por: Yang, Man, et al.
Publicado: (2021)

The evaluation of ENGBD versus PTGBD in high-risk acute cholecystitis: A single-center prospective randomized controlled trial
por: Mu, Peilei, et al.
Publicado: (2020)

Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?
por: Lee, Chansu, et al.
Publicado: (2016)

Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats
por: Yang, Yu-Chen S. H., et al.
Publicado: (2020)

No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants
por: He, Qiangsheng, et al.
Publicado: (2021)

Monthly Digest: For May
Publicado: (1889)

Dietary supplemental xylooligosaccharide modulates nutrient digestibility, intestinal morphology, and gut microbiota in laying hens
por: Zhou, Jianmin, et al.
Publicado: (2021)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Progress with proton pump inhibition.
por: Bell, N. J., et al.
Publicado: (1992)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Does proton pump inhibitors use increase risk of digestive tumors?: A 2-sample Mendelian randomization study
por: Zhao, Ruiqi, et al.
Publicado: (2023)

Disturbance in the oropharyngeal microbiota in relation to antibiotic and proton pump inhibitor medication and length of hospital stay
por: Tranberg, Anna, et al.
Publicado: (2020)

Pump Proton and Laryngeal H(+)/K(+) ATPases
por: Zhang, Zhe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2g8q0r8ivcrc24k3h4kg5h2g9l